Rapidly Progressive Complications of the Influenza A Type in Children
Authors:
J. Kobr 1; K. Pizingerová 1; L. Šašek 1; J. Fremuth 1; P. Honomichl 1; R. Vondráková 2; J. Kudová 3; T. Bergerová 3; J. Racek 4
Authors place of work:
Dětská klinika, Univerzita Karlova v Praze, Lékařská fakulta v Plzni a Fakultní nemocnice Plzeň
přednosta doc. MUDr. J. Kobr, PhD.
1; Klinika zobrazovacích metod, Univerzita Karlova v Praze, Lékařská fakulta v Plzni a Fakultní nemocnice Plzeň
přednosta doc. MUDr. B. Kreuzberg, CSc.
2; Ústav mikrobiologie, Univerzita Karlova v Praze, Lékařská fakulta v Plzni a Fakultní nemocnice Plzeň
vedoucí RNDr. K. Fajfrlík, PhD.
3; Ústav klinické biochemie a hematologie, Univerzita Karlova v Praze, Lékařská fakulta v Plzni a Fakultní nemocnice Plzeň
vedoucí prof. MUDr. J. Racek, DrSc.
4
Published in the journal:
Čes-slov Pediat 2010; 65 (6): 386-393.
Category:
Original Papers
Summary
Introduction:
The aim of the study was the effects of active prevention and reducing the overall length of hospital stay increases the effectiveness of treatment of pulmonary complications of influenza type A in children.
Design:
Clinical, prospective study in Department of Paediatrics-PICU, University Hospital in Pilsen.
Material and methods:
Including criteria were acute lung injury (ALI) and ongoing infection of influenza type A. Children without evidence of this infection were excluded. Between October and December 2009 a total of 9 children were enrolled, average age of 6.2 years (range 0.3–15 years). Anti-infective treatment was conducted combining antivirals and antibiotics.
Results:
Influenza A virus isolation and RNA virus in tracheal aspirate showed ongoing infection in 9 children, in 6 children (67%) with Pandemic A (H1N1) 2009 subtype. Bacterial co-infection was detected in 8 children (89%). Acute lung injury corresponded to the average Lung Injury Score File (LIS; 1.9±0.76 points). Index Predicted Risk of Mortality Score (PRISM; 14.7±8.67 points) predicted 12% mortality for the group. Chronic risk existed in 6 children, but they were not vaccinated. Mechanical ventilation of 5 children lasted an average of 11.2±3.29 and non-invasive ventilation of 3 children an average of 1.9±0.85 days. Four children had unilateral chest empyema and 3 children had pneumothorax. Thoracic drainage lasted an average of 7.8±5.56 days. Data analysis confirmed the correlation between the absence of vaccination (r=0.989; p<0.001), bacterial co-infection (r=0.543; p<0.01) and chronic risk (r=0.425; p<0.05) on the one hand and the severity of lung impairment on the other hand. All nine children from the study were clinically healed with minimal residual pulmonary findings. The average length of hospitalization of our patients was 17.33±3.27 days.
Conclusions:
The absence of vaccination, bacterial co-infection and chronic risk were the factors development of severe pulmonary complications during the influenza in children. Early launch of a comprehensive treatment was effective in preventing permanent disability.
Key words:
influenza A type, acute lung injury, bacterial co-infection, thoracic empyema, chronic risk, vaccination
Zdroje
1. Zarocostas J. H1N1 pandemic flu found to cause viral pneumonia in severe case says WHO. Brit. Med. J. 2009;doi: 10.1136/bmj.b4313.
2. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Qiuňones-Falconi F, et al. Intensive-care patients with severe novel influenza A (H1N1) virus infection-Michigan. MMWR Morb. Mortal Wkly Rep. 2009; 58: 749–752.
3. Trupy RD. Ethical assessment of pediatric research protocols. Intensive Care Med. 2008; 34: 198–202.
4. Oikonomou A, Müller NL, Nentel S. Radiographic and high-resolution CT findings of influenza virus pneumonia in patients with hematologic malignancies. Am. J. Roentgenol. 2003: 181: 507–511.
5. Agarwal PP, Cinti S, Kayerooni EA. Chest radiographic and CT findings in novel Swine-origin influenza A (H1N1) virus (S-OIV) infection. Am. J. Roentgenol. 2009; http://ajponline.org/ahaedofprint/ 12_09_3599.pdf.
6. Lung Injury Score Download, upgrade 2009; http://www.pdacortex/Lung_Injury_Score_Down- load.htm.
7. ADO index may help Predict Risk for Mortality from COPD, upgrade 2009; http://www. medscape.com/viewarticle/708492.
8. VAXIGRIP® Data Sheet, upgrade 2009; http://www.influenza.org.nz/site_resources/influen-za%202009/vaxigrip_datasheet_2009.pdf.
9. European Medicines Agency Pandemic influenza (H1N1) vaccine information, Pandemrix, 2009; http://www.ema.eurpa.eu/influenza/vaccines/pande-mrix/pandemrix.html.
10. European Medicine Agency Pandemic influenza (H1N1) website, European strategy for influenza A/H1N1 vaccines benefit-risk monitoring. Vaccine information, 2009; http://www.ema.europa. eu/influenza/vaccines/home.htm.
11. Prevenar 13, pneumokoková polysacharidová konjugovaná vakcína (13-valentní, adsorbovaná), 2009; http://ema.europa.eu/humandocs/pdfs/epar/prevenar 13/h-1104-cs1.pdf.
12. Oseltamivir-Wikipedia, 2009; http.://en.wikipedia. org/wiki/oseltamivir.
13. Zanamivir-Wikipedia, free file, 2009; http://en.wikipedia.org/wiki/File:Zanamivir.png.
14. Influenza (Flu) in Healthcare Settings. Guideline Excerpt from: Guidelines for Preventing Healthcare Associated Pneumonia: Healthcare-Associated Influenza (Flu) Guidelines. Date last modified: April 15, 2009, Content source: Division of Healthcare Quality Promotion (DHQP), National Centre for Preparedness, Detection, and Control of Infectious Diseases; http://www.cdc.gov./ncidod/dhqp/id_ influenza_pneuExcerpt.html.
15. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-including ligand. J. Exp. Med. 2008; 205(13): 3065–3077.
16. Martin TR, Hagimoto N, Nakanuta M, Matute-Bell G. Apoptosis and epithelial injury in the lungs. Proc. Am. Thorac. Soc. 2005; 2: 214–220.
17. Lin KL, Sužuji Y, Nakano H, Ramsburg E, Guán MD. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J. Immunol. 2008; 180: 2562–2572.
18. Akaike T, Noguchi Y, Ujiti S, Setoguchi K, Suga M, et al. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 2009; 93: 2448–2453.
19. Choi AM, Knobil K, Otterbein SL, Eastman DA, Jakoby DB. Oxydant stress response in influenza virus pneumonia: gene expression and transcription factor activation. Am. J. Physiol. Lung Cell Mol. Physiol. 1996; 272: 383–391.
20. Medical News Today. Analysis of the Connection between Flu and pneumonia. Helmholtz Centre for Infection Research; upgrade 2009; http://www. medicalnewstoday.com/articles/142829.php.
21. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Qiuňones- Falconi F, et al. Pneumonia and respiratory failure from Swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med. 2009; 361: 680–689.
22. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Qiuňones-Falconi F, et al. Intensive-care patients with severe novel influenza A (H1N1) virus infection-Michigan. MMWR Morb. Mortal. Wkly Rep. 2009; 58: 749–752.
23. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 2009; 360: 2605–2615.
24. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Hospitalized patients with novel influenza A (H1N1) virus infection-California. MMWR Morb. Mortal. Wkly Rep. 2009; 58: 536–541.
25. Rello J, Rodrigez A, Ibanez P, Socias L, Cebrian J, group THNSw. Intensive care adult patients with severe respiratory failure cause by influenza A(H1N1)v in Spain. Crit. Care 2009; 13: R148.
26. Kuhn GJ. Pneumonia, Viral. eMedicine Emergency Medicine, 2009; http://emedicine. medscape.com/article/808013.
27. Gusta RK, Nguyen-Van-Tam RG, Nguyen-Van-Tam JS. Bacterial pneumonia and pandemic influenza planning. Emerg. Infect. Dis. upgrade 2008; http://www.cdc.gov/EID/content/14/8/1187.htm.
28. Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implifications for pandemic preparedness. Lancet Infect. Dis. 2006; 6: 303–312.
29. Al-Kaabi N, Solh Z, Pacheco S, Murray L, Gaboury I, Le Saoux N. A comparison of group A streptococcus versus Streptococcus pneumoniae pneumonia. Pediatr. Infect. Dis. J. 2006; 25: 1008–1012.
30. Kawayama T, Fujiki R, Rikimaru T. Clinical study of severe influenza pneumonia that cause acute respiratory failure. Kurume Med. J. 2009; 48(4): 273–279.
31. Quispe-Laime AM, Bracco JD, Barberio PA, Rolfo VE, Umberger R, Meduri GU. H1N1 influenza A virus – associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med. 2010; 36: 33–41.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2010 Číslo 6
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Body Temperature and Thermoregulation in the Newborn
- Rapidly Progressive Complications of the Influenza A Type in Children
- Methotrexate in Children with Juvenile Idiopathic Arthritis
- Thromboembolic Events in Girls and Young Women Taking Hormonal Contraception